MedTrace Logo

DNA Changes in Patients With Prostate Cancer

NCT00899184 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 646

Last updated 2017-05-19

No results posted yet for this study

Summary

RATIONALE: Collecting and storing samples of blood from patients and their brothers with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer.

PURPOSE: This laboratory study is looking at changes in DNA in patients and their brothers with prostate cancer.

Conditions

Interventions

GENETIC

polymorphism analysis

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • ECOG-ACRIN Cancer Research Group

    lead NETWORK

Principal Investigators

  • Kim M. Hirshfield, MD, PhD · Rutgers Cancer Institute of New Jersey

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-05-23
Primary Completion
2007-05-30
Completion
2007-05-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00899184 on ClinicalTrials.gov